Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.10 | 0.10 | 0.00 |
Stocks | 90.64 | 90.64 | 0.00 |
Convertible | 0.13 | 0.13 | 0.00 |
Other | 9.14 | 9.14 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.98 | 19.78 |
Price to Book | 4.65 | 4.58 |
Price to Sales | 2.11 | 2.64 |
Price to Cash Flow | 19.28 | 17.68 |
Dividend Yield | 0.72 | 1.05 |
5 Years Earnings Growth | 11.32 | 13.95 |
Number of long holdings: 142
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.48 | 785.41 | +2.45% | |
Aggregate Miscellaneous Equity | - | 9.14 | - | - | |
UnitedHealth | US91324P1021 | 8.46 | 532.51 | +0.52% | |
Intuitive Surgical | US46120E6023 | 5.41 | 584.05 | -4.04% | |
Thermo Fisher Scientific | US8835561023 | 4.19 | 574.82 | -0.01% | |
Stryker | US8636671013 | 4.08 | 394.31 | +0.21% | |
Danaher | US2358511028 | 3.51 | 245.80 | +0.06% | |
argenx ADR | US04016X1019 | 3.33 | 648.94 | -0.50% | |
Vertex | US92532F1003 | 2.48 | 439.62 | -0.03% | |
Merck&Co | US58933Y1055 | 2.41 | 95.55 | -1.12% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 35.86B | 12.69 | 5.65 | 10.55 | ||
T. Rowe Price Blue Chip Growth | 33.33B | 35.63 | 7.54 | 14.89 | ||
T. Rowe Price Blue Chip Growth I | 30.64B | 35.79 | 7.68 | - | ||
T. Rowe Price Capital AppreciationI | 29.54B | 12.84 | 5.78 | - | ||
T. Rowe Price Instl Large Cap Growt | 22.91B | 30.99 | 7.47 | 16.14 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review